E1764 CONGRESSIONAL RECORD — Extensions of Remarks October 12, 2000 STARK CALLS FOR FURTHER FDA thermore, in addition, infusion services are nancial incentive for doctors to increase INVESTIGATION INTO ABUSE OF invasive procedures that are painful and, their usage of Vancomycin at a time when AVERAGE WHOLESALE PRICE when unnecessary, reduce the quality of America is experiencing a health crisis, is SYSTEM life.’’ reprehensible conduct and clearly warrants ‘‘Based on a survey of infusion suppliers in an FDA investigation. , we found that charges for infusion You may question why a major drug com- drugs varied widely, from as little as Aver- HON. FORTNEY PETE STARK pany would engage in this deplorable con- age Wholesale Price (AWP), which is gen- OF duct? Abbott’s direct benefit from its false IN THE HOUSE OF REPRESENTATIVES erally considered a reference price for drugs by the pharmaceutical industry, to more price manipulation is demonstrated by data Wednesday, October 11, 2000 than 20 times AWP.’’ (Page #6) (enclosed as Exhibit #4 provided by the in- 2. The public health consequences of the drug dustry insider pursuant to a congressional Mr. STARK. Mr. Speaker, I today sent the subpoena) for calendar year 1996 from the following letter to the FDA, in support of an in- pricing manipulation by certain companies for the IV antibiotic Vancomycin, the drug of last State of Florida’s Pharmacy Pro- vestigation of how some of the nation's lead- resort for many life theratening infections. Ex- gram. The data outline Florida Medicaid’s ing drug manufacturers are using false pricing hibit #2 features an article from Hospital reimbursements paid to the customers of Ab- data to distort the practice of medicine in Pharmacist Report entitled Under Attack bott and utilization of Abbott’s generic America. The data in the letter is an indict- Vancomycin-resistant S. Aureus Hits U.S. Vancomycin. Abbott maximized sales vol- ment of the companies' abuse of the taxpayer Shores. ‘‘The widespread, and often unwar- ume and captured the Florida medicaid phar- and of the patient. ranted, use of antimicrobial agents, particu- macy market for Vancomycin by causing the Florida Medicaid program to substantially I submit the following letter into the RECORD: larly vancomycin is a major contributing factor in the emergence of S. aureau with di- inflate reimbursement to the detriment of HOUSE OF REPRESENTATIVES, minished susceptibility to vancomycin.’’ In- Florida’s Medicaid Program. As you know, Washington, DC, October 10, 2000. deed, as stated in the article, the problem drug companies capture market share and Dr. JANE E. HENNEY, has reached the level where the CDC has maximize sales volume by concealing true Commissioner, Food and Drug Administration, called for strict limits on the use of this drug prices while falsely representing grossly Rockville, MD. vital drug. ‘‘Published in the MMWR, de- inflated prices which in turn creates a spread DEAR DR. HENNEY: I am writing you to sup- tailed recommendations for preventing and between the providers’ costs and the amount plement my recent letter of October 3, 2000. of reimbursement paid by Medicaid or Medi- I would request that any FDA investigation controlling S. aureus with diminished sus- ceptibility to vancomycin emphasize strict care. As a result, Abbott has captured the into whether certain drug companies have majority of the market (at least for Med- engaged in conduct that violates FDA rules adherence to contact isolation precautions and their recommended infection control icaid) by creating a financial incentive for or regulations take into account the fol- doctors to increase their usage of the over- lowing: practices, judicious use of vancomycin . . .’’ (emphasis added). prescribed drug (Exhibit #5—prepared by the 1. The findings contained in the HHS–OIG re- National Association of Medicaid Fraud Con- port entitled Infusion Therapy Services Pro- Enclosed as composite Exhibit #3 (provided by the industry insider pursuant to a con- trol Units in conjunction with their ongoing vided in Skilled Nursing Facilities (December investigation). 1999 A–06–99–00058) Exhibit #1. The OIG’s inde- gressional subpoena) is: 1. Listings from the 1995, 1996 & 1999 Red pendent findings provide compelling evi- The insider’s evidence demonstrates that Book for Abbott’s generic Vancomycin. dence of the magnitude, cost and public providers will purchase and utilize the phar- 2. Copies of advertisements from Florida maceutical manufacturer’s product that has health issues resulting from drug price ma- Infusion for the years ’95, ’96 and ’99 for Ab- nipulation of the Medicare program. the widest spread between the provider’s bott’s genreic Vancomycin. true cost and the reimbursement paid by The following excerpts from the above ref- The following chart summarizes Exhibit 3: erenced OIG report are particularly note- third parties (including the States’ Medicaid Programs and Medicare). For example, 1996 worthy: ABBOTT’S VANCOMYCIN ‘‘Our review of three infusion suppliers, for reimbursement demonstrates that the manu- the period 1995 through 1998, showed they [1 gm. 10s NDC#00074–6533–01] facturer which causes the widest spread, ben- efits from the highest utilization. The phar- provided infusion therapy services to Medi- Florida infu- Difference be- care-reimbursed SNFs that were excessively maceutical manufacturers Abbott, Fujisawa, Year Red Book Red Book sion true tween AWP & true priced and unnecessary.’’ (Page #1) AWP DP wholesale price ‘‘The Lederle Lilly and Schein all made represen- ‘‘At the 22 SNFs, $4.8 million out of $9 mil- price Spread’’ tations of Wholesaler Acquisiton Cost lion in claims reviewed (53 percent) were not 1995 ..... 604.44 $8.40/1 gm $52.04 (‘‘WAC’’) to the State of Florida as illus- medically necessary.’’ (Page #1) (60.44/1 gm.) trated in the chart below. The chart further ‘‘In addition to the financial effects we 1996 ..... 628.66 $7.95/1 gm $54.91 sets out the number of reimbursed claims, (62.86/1 gm.) noted above, overutilization and overpricing 1999 ..... 727.82 612.90 74.00 ($7.40/ $65.38 the insider’s cost and ‘‘the spread’’ between were potentially harmful to the patients. (72.78/1 gm.) 1 gm.) Medicaid reimbursement and true cost. A re- Medical reviewers who were part of our audit view of the chart clearly demonstrates that concluded that patients receiving unneces- As the above chart also demonstrates, Ab- the vast majority of providers utilize the sary infusion therapy services were placed at bott actually raised its representations of manufacturer’s pharmaceutical with the undue risk for complications, including in- AWP from 1996 to 1999 while the true whole- greatest spread between the true Wholesale creased risk of infection, fluid and electro- sale price to providers fell from $7.95 to $7.40. Acquisition Cost and the inflated false WAC lyte imbalance, and medical reactions. Fur- Abbott’s price manipulation, creating a fi- reported by Abbott. 1996 FLORIDA MEDICAID UTILIZATION FOR VANCOMYCIN HCL 1 GRAM

Florida Medicaid Reimburse- % of Company/NDC True Reim- The ment paid by market cost $ burse- spread Florida Med- share ment icaid

Abbott/00074–6533–01 ...... $7.95 $58.75 $50.80 $381,480.78 83.37 Fujisawa/00469–2840–40 ...... 6.42 13.91 7.49 19,023.54 4.16 Lederle/00205–3154–15 ...... 3.98 9.36 5.38 21,297.64 4.65 Lilly/00002–7321–10 ...... 14.30 13.35 (0.95) 19,096.96 4.17 Schein/00364–2473–91 ...... 6.05 12.52 6.47 16,672.18 3.64

It is important to note that Abbott pub- nancial incentive to the provider. The fol- chart specifying numerous drugs for which lishes and reports truthful prices for many of lowing attached as composite Exhibit #6 is a Abbott reports truthful prices: its drugs when it does not seek to create a fi- ABBOTT LABS 1999 REPRESENTATIONS OF PRICES AND COST AND STATES’ MEDICAID REIMBURSEMENT

Bergen Provider Red Book Brunswig cost with Drug Strength & Size, NDC# 00074– AWP cost 7% up- Florida Medicaid WAC + 7% Medicaid AWP–10% (WAC*) charge

Biaxin 500 MG, 60S NDC#2586–60 ...... $195.59 $164.13 $175.62 175.62 Spread $0.00 ...... $176.04 Spread $0.42 (0.2%). Cartol 5mg, 100s NDC#166–13 ...... 106.18 88.76 94.97 94.97 Spread $0.00 ...... $95.57 Spread $0.60 (0.6%). Cylert Tablets 37.5mg, 100s NDC# 6057–13 ...... 144.84 121.67 130.18 130.18 Spread $0.00 ...... $130.36 Spread $0.18 (0.1%).

VerDate 112000 06:11 Oct 13, 2000 Jkt 089060 PO 00000 Frm 00016 Fmt 0626 Sfmt 0634 E:\CR\FM\A12OC8.000 pfrm04 PsN: E12PT1 October 12, 2000 CONGRESSIONAL RECORD — Extensions of Remarks E1765 ABBOTT LABS 1999 REPRESENTATIONS OF PRICES AND COST AND STATES’ MEDICAID REIMBURSEMENT—Continued

Bergen Provider Red Book Brunswig cost with Drug Strength & Size, NDC# 00074– AWP cost 7% up- Florida Medicaid WAC + 7% New York Medicaid AWP–10% (WAC*) charge

Depakote 250mg, 100s NDC# 6214–11 ...... 82.66 69.30 74.15 $74.15 Spread $0.00 ...... $74.40 Spread $0.25 (0.3%). * WAC—Wholesaler Acquisition Cost (7 states use WAC for reimbursement).

3. Examination of another Medicare reim- most no Medicare utilization while it was cial inducement. As the chart below indi- bursed drug further confirms that the drug man- under patent and not subject to any generic cates, Medicare utilization has gone from ufacturers engaging in the price manipulation competition. Sometime in 1997, Atrovent $14,426,108.00 in 1995 to $253,400,414.00 in 1998. are correct when they assume that the financial came off patent and became subject to ge- The spread has gone from virtually zero to incentives they arrange will increase the usage neric competition. Certain manufacturers of over 100%! of their drugs. Atrovent (Ipratropium Bro- the generic form of the drug began to make mide) is an inhalant medication that had al- false price representations to create a finan-

True cost Medicare Reim- per Spread Spread Medicare ex- Year bursement amount Medi- $ % penditures per unit* care unit**

1995 ...... $3.11 ($0.62/ml) $3.11 0.00 0 $14,416,108 1996 ...... 3.75 (0.75/ml) 3.26 0.49 15 47,388,622 1997 ...... 3.50 ($0.70/ml) 2.15 1.35 63 96,204,639 1998 ...... 3.34 1.70 1.64 96 176,887,868 1999 ...... 3.34 1.60 1.74 108 253,400,424 * Medicare Units were converted from ml’s to mg’s for the years 1995, 1996 & 1997 (5 ml=1 milligram).

Would you please advise me if the FDA ganization for Security and Cooperation in Eu- rial linkages (an exercise in futility). since 1995 has approved any other additional rope as well as numerous non-governmental Kazakhstan is the most Russified Central indications that might explain the dramatic human rights organizations, to insist that Asian state, with close to 30 percent of its increase in the utilization of Ipratropium population Russians who serve as the main Bromide. Is there any medical reason for Nazarbayev fulfill the promises he made on scientific industrial and business elite. these noted utilization increases? human rights and free elections as a price for However, the Clinton administration sank It is essential that the Health Care Financ- legitimacy in American eyes. Sadly, however, into the pool of oil that inadvertently led to ing Administration and other government it seems clear that Clinton-Gore Administration the most serious corruption of the reimbursement authorities receive truthful has pulled its punches, because it wants oil Nazarbayev dictatorship by failing to resist and accurate information from drug manu- rich Kazakhstan's support for an oil pipeline the dictatorship. One of the administration’s facturers regarding drugs for which the gov- major foreign policy goals was humanitarian ernment reimburses. The evidence uncovered that does not go through Russia. What is par- ticularly troublesome in this regard is that the intervention to help bring an end to former by the Congressional investigation to date communist dictatorships in the former So- reveals a conscious, concerted and successful United States should not be turning a blind viet Union and the Balkans. effort by some drug makers to actively mis- eye to repression and corruption in order to In fact, the administration conducted a lead the Health Care Financing Administra- persuade Kazakhstan to do something that is ‘‘humanitarian war’’ in Kosovo. The idea of a tion and others about the price of their in its interest in any event. humanitarian and exemplary intervention, drugs. As the federal agency possessing pri- Mr. Speaker, I would like to submit Pro- i.e. support of opposition groups in mary regulatory responsibility with respect Kazakhstan, free press, and democracy was to drug makers’ representations about their fessor Perlmutter's article for the RECORD. sacrificed, unfortunately, to the pool of oil. products, I urge the Food and Drug Adminis- MORE WORDS THAN DEEDS ON KAZAKHSTAN? The administration was not directly in- tration to take immediate action before the (By Amos Perlmutter) present fiscal and public health con- volved in support of the dictatorship. But it sequences reach a catastrophic level. The Clinton-Gore administration relation- failed to vigorously resist the Nazarbayev Sincerely, ship with Nursultan Nazarbayev’s corrupt violation of human rights, dissolution of the Kazakh parliament on two occasions, and PETE STARK, dictatorship in Kazakhstan is, once again, . making news. Not without reason. above all the closing the only two opposition The case is that the administration failed papers and the rigging of the 1999 elections. f to defend political freedom and free enter- In defense of the administration you could prise in Kazakhstan. They talked the talk say diplomatic gobbledygook and securing WRONG ON KAZAKHSTAN without walking the walk when it come to unfulfilled promises form Mr. Nazarbayev challenging the Nazarbayev dictatorship. was unfortunately subordinated to oil and HON. DAN BURTON Promises from Mr. Nazarbayev went nuclear strategic policies. The embassy in OF INDIANA unfulfilled. The administration failed to sup- Kazakhstan continuously reported to the IN THE HOUSE OF REPRESENTATIVES port the claims of human rights organiza- U.S. State Department on Mr. Nazarbayev’s tions, non-government organizations (NGOs), violations of human rights. Wednesday, October 11, 2000 and the OSCE that the Nazarbayev govern- In fact, the OSCE, human rights groups, Mr. BURTON of Indiana. Mr. Speaker, I ment is not only failing to undergo demo- non-government organizations (NGOs), and would like to draw the attention of my col- cratic changes as a price for support from other groups have warned the administration leagues to a very disturbing Op Ed article by the United States, but also is relentlessly de- and continuously protested Mr. Nazarbayev’s Professor Amos Perlmutter (``More words than stroying the opposition, closing the free dictatorship and suppression of freedom in deeds on Kazakhstan?'' in the Washington press and involving itself in corrupt schemes. Kazakhstan. Leon Fuerth, Vice President Al The effort to support this regime was con- Gore’s national security adviser, and his as- Times of October 4, 2000), detailing how the ceived in conformity with the American na- sistant, Richard Brody, met on Sept. 15, 1999, Clinton-Gore Administration has dropped the tional interest. After all, there are three rea- at the Old Executive Office Building to dis- ball in promoting democracy and respect for sons for U.S. strategic interest in cuss Nazarbayev to the United States. At- human rights in Kazakhstan. Kazakhstan: oil, nukes and independence. tending were several people from the State Time after time, Kazakhstan's ruthless and Kazakhstan has been one of the Soviet Department, regional and human rights bu- corrupt President, Nursultan Nazarbayev, has Union’s major oil reserves, and continues to reaus, as well as the Human Rights Founda- made promises to Vice President Gore and be a most significant oil reserve and also a tion, and the Kazakhstan 21st Century Foun- others in the Administration and has then Caspian littoral state. Josef Stalin made dation. failed to deliver on those promises. And so as Kazakhstan a Soviet nuclear arsenal. Mr. Fuerth was on the defensive through- Independence was the goal of both the out the meeting, as the various representa- Professor Perlmutter puts it, the Nazarbayev Bush and Clinton administrations, to tives pressed hard the argument that the regime continues its campaign of ``relentlessly strengthen Central Asia non-Russian Muslim meeting was a mistake at that time, since destroying the opposition, closing the free states, and to move them in the direction of Mr. Nazarbayev would interpret it as an en- press and involving itself in corrupt schemes.'' democracy and free enterprise. There was a dorsement of his behavior. According to one It should have been possible for the United tacit strategic purpose in separating of the participants, Mr. Fuerth was States, which has had the support of the Or- Kazakhstan from Russia’s historical impe- unpersuasive and ineffective in defending the

VerDate 112000 06:11 Oct 13, 2000 Jkt 089060 PO 00000 Frm 00017 Fmt 0626 Sfmt 0634 E:\CR\FM\A11OC8.057 pfrm04 PsN: E12PT1